Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-06-06 |
2024-03 |
0 |
N/A |
N/A |
N/A |
2024-04-04 |
2023-12 |
0 |
N/A |
N/A |
N/A |
2023-11-09 |
2023-09 |
0 |
-0.9 |
N/A |
N/A |
2023-08-10 |
2023-06 |
0 |
-0.49 |
N/A |
N/A |
2023-05-11 |
2023-03 |
-1.47 |
-0.81 |
0.66 |
44.90% |
2023-03-09 |
2022-12 |
-0.47 |
-0.61 |
-0.14 |
-29.79% |
Date |
Firm |
Action |
From |
To |
2022-03-29 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2021-08-30 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2021-06-04 |
Canaccord Genuity |
Upgrade |
|
Buy |
2021-03-04 |
Canaccord Genuity |
Upgrade |
|
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2017-01-08 |
CASHION CHARLES J |
Chief Financial Officer |
187.16K |
Conversion of Exercise of derivative security |
2015-04-07 |
KISNER DANIEL L |
Director |
7.15K |
Purchase |
2020-05-21 |
MARSHALL KEITH W. |
Chief Operating Officer |
19.89K |
Conversion of Exercise of derivative security |
2020-05-21 |
MENTO STEVEN J |
Director |
82.28K |
Conversion of Exercise of derivative security |
2021-03-29 |
PASCOE RICHARD W |
Chief Executive Officer |
30.00K |
Purchase |
2018-11-13 |
RIPLEY DANIEL L. |
Officer |
0.00 |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-03-30 |
Vanguard Group, Inc. (The) |
60.17K |
47.59K |
1.41% |
2023-03-30 |
Blackrock Inc. |
34.91K |
27.61K |
0.82% |
2023-03-30 |
Millennium Management Llc |
26.54K |
20.99K |
0.62% |
2023-03-30 |
Susquehanna International Group, LLP |
15.49K |
12.25K |
0.36% |
2023-03-30 |
Two Sigma Securities, LLC |
12.82K |
10.14K |
0.30% |
2023-03-30 |
Geode Capital Management, LLC |
10.39K |
8.22K |
0.24% |
Report Date |
Organization |
Position |
Value |
Percentage |
2022-12-30 |
Vanguard Extended Market Index Fund |
13.64K |
10.79K |
0.32% |
2023-02-27 |
Fidelity Extended Market Index Fund |
7.00K |
5.54K |
0.16% |
2023-02-27 |
Fidelity NASDAQ Composite Index Fund |
2.61K |
2.07K |
0.06% |
2023-02-27 |
Fidelity Series Total Market Index Fund |
612.00 |
484.00 |
0.01% |
2023-02-27 |
Fidelity Total Market Index Fund |
128.00 |
101.00 |
0.00% |
2023-02-27 |
iShares Core S&P Total U.S. Stock Market ETF |
67.00 |
52.00 |
0.00% |
Split |
Date |
1 : 20 |
2022-06-03 |
1 : 10 |
2020-05-27 |